14 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 29471671 | Cholesterol-enriched membrane microdomains are needed for insulin signaling and proliferation in hepatic cells. | 2018 Jul 1 | 1 |
2 | 26491824 | Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association. | 2015 Oct | 1 |
3 | 18078859 | Statin modulates insulin signaling and insulin resistance in liver and muscle of rats fed a high-fat diet. | 2008 Jan | 5 |
4 | 15584598 | [Thrombocytic hemostasis in hypertensive patients with metabolic syndrome and its correction with lovastatin]. | 2004 | 1 |
5 | 14517078 | Cholesterol requirement of hepatitis B surface antigen (HBsAg) secretion. | 2003 Sep 15 | 2 |
6 | 11696371 | Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes. | 2001 Nov 2 | 2 |
7 | 11716532 | Phosphatidylinositol 3-kinase and Ras/mitogen-activated protein kinase signaling pathways are required for the regulation of 5-aminolevulinate synthase gene expression by insulin. | 2001 Dec 10 | 1 |
8 | 11387965 | [Effects of lovastatin on plasma lipid, plasma glucose and insulin metabolism of patients with type II B hyperlipemia]. | 1999 Dec | 2 |
9 | 9381994 | Comparison of bezafibrate versus lovastatin for lowering plasma insulin, fibrinogen, and plasminogen activator inhibitor-1 concentrations in hyperlipemic heart transplant patients. | 1997 Oct 1 | 1 |
10 | 9430371 | Mevalonate deprivation impairs IGF-I/insulin signaling in human vascular smooth muscle cells. | 1997 Dec | 1 |
11 | 9459136 | Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment. | 1997 Nov | 1 |
12 | 8935222 | Lovastatin lowers serum cholesterol levels in non-insulin-dependent diabetes mellitus patients without altering their insulin sensitivity. | 1996 Mar | 2 |
13 | 7836430 | Differential requirement for p21ras activation in the metabolic signaling by insulin. | 1995 Feb 3 | 2 |
14 | 1953779 | Inhibition of growth factor signaling pathways by lovastatin. | 1991 Nov 14 | 1 |